Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Novo Nordisk A/S Recent news which mentions Novo Nordisk A/S < Previous 1 2 3 4 5 6 Next > Here are the big health sector themes to watch next year December 22, 2023 Tags Humana Inc Stock markets Pfizer Inc From CNBC.com News Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma December 20, 2023 Tags Health & Science Pharmaceuticals Amgen Inc From CNBC.com News 5 things to know before the stock market opens Monday December 18, 2023 Tags Novo Nordisk A/S Nike Inc Investing From CNBC.com News The weight loss drug boom isn't over yet — here's what to expect in the year ahead December 17, 2023 Tags Pfizer Inc Novo Nordisk A/S US: News From CNBC.com News Patients regain weight after stopping Eli Lilly's Zepbound, study says December 11, 2023 Tags Breaking news Companies Health care industry From CNBC.com News Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages December 05, 2023 Tags Breaking news Companies Cigna Corp From CNBC.com News An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024 December 05, 2023 Tags Investment strategy World Economy Breaking News: Investing From CNBC.com News Cramer says the growing popularity of weight loss drugs brings new investing opportunities December 04, 2023 Tags Business News Investment strategy Investment Strategy From CNBC.com News Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops December 02, 2023 Tags Companies Business Abbott Laboratories From CNBC.com News Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects December 01, 2023 Tags Novo Nordisk A/S Eli Lilly and Co US: News From CNBC.com News Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs November 30, 2023 Tags Companies Business Health & Science From CNBC.com News Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says November 27, 2023 Tags Biotechnology Biotech and Pharmaceuticals Science From CNBC.com News Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members November 13, 2023 Tags Markets Stock Picks stocks From CNBC.com News Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success November 13, 2023 Tags US: News Eli Lilly and Co Novo Nordisk A/S From CNBC.com News 5 things to know before the stock market opens Monday November 13, 2023 Tags Markets Target Corp Politics From CNBC.com News Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events November 11, 2023 Tags Business Health & Science Pharmaceuticals From CNBC.com News Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index November 10, 2023 Tags ServiceNow Inc Novo Nordisk A/S U/S/ Markets From CNBC.com News Cramer's Lightning Round: Buy AutoZone November 09, 2023 Tags Business News Investment strategy Investment Strategy From CNBC.com News FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug November 08, 2023 Tags Social issues Novo Nordisk A/S Eli Lilly and Co From CNBC.com News Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month November 02, 2023 Tags Pharmaceuticals Health & Science Business From CNBC.com News Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S. November 02, 2023 Tags Pharmaceuticals Health & Science Novo Nordisk A/S From CNBC.com News Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says November 02, 2023 Tags Business News Novo Nordisk A/S US: News From CNBC.com News Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook November 02, 2023 Tags Eli Lilly and Co US: News Novo Nordisk A/S From CNBC.com News Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs October 31, 2023 Tags Spin/offs Business News Biotechnology From CNBC.com News As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data October 24, 2023 Tags Weight management Health & Science Apple Inc From CNBC.com News CNBC Daily Open: Oil deals ahead of Big Tech earnings October 24, 2023 Tags Exxon Mobil Corp Inflation Arm Holdings PLC From CNBC.com News CNBC Daily Open: Oil deals and awaiting tech earnings October 23, 2023 Tags Intel Corp Consumer prices Markets From CNBC.com News Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers October 23, 2023 Tags Novo Nordisk A/S Health care industry Breaking News: Investing From CNBC.com News Sanofi to offer insulin product for $35 to all Americans through GoodRx October 19, 2023 Tags Biotech and Pharmaceuticals Biotechnology Business News From CNBC.com News 'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles October 14, 2023 Tags Wall Street Pharmaceuticals Markets From CNBC.com News < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.